High dose cisplatin and high dose carboplatin in refractory ovarian cancer
- 30 September 1985
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 12, 59-65
- https://doi.org/10.1016/0305-7372(85)90019-2
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- High-dose cisplatin in hypertonic saline in refractory ovarian cancer.Journal of Clinical Oncology, 1985
- A Phase I trial of Cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-scheduleInvestigational New Drugs, 1984
- High-Dose Cisplatin in Hypertonic SalineAnnals of Internal Medicine, 1984
- JM8, SUCCESSOR TO CISPLATIN IN ADVANCED OVARIAN CARCINOMA?The Lancet, 1983
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982
- USE OF HIGH DOSE CIS-DICHLORODIAMMINE PLATINUM (II) (NSC-119875)+ FOLLOWING FAILURE ON PREVIOUS CHEMOTHERAPY FOR ADVANCED CARCINOMA OF THE OVARYBJOG: An International Journal of Obstetrics and Gynaecology, 1981
- High-dose platinum for the treatment of refractory ovarian cancerGynecologic Oncology, 1981